Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ear zaps may boost brain and sleep in seniors

NCT ID NCT07416708

Symptom relief Sponsor: Balnear and Rehabilitation Sanatorium Techirghiol Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device that gently stimulates a nerve in the ear to see if it can improve thinking, sleep, and inflammation in older adults with frailty. Eighty people over 60 received either the active stimulation or a sham version, along with standard physical therapy, for two weeks. Researchers measured changes in cognitive tests, sleep quality, and blood markers of inflammation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous auricular vagus nerve stimulation (taVNS) device
What this could lead to
If it works, this could offer a simple, non-invasive way to help older adults think more clearly and sleep better.
What could go wrong
This was a small, short-term study (80 people, 2 weeks) with no phase. The results may not apply to everyone, and the sham group might also improve from other therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Dec 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age ≥ 60 years. * Vertebro-peripheral osteoarthritic disease without contraindication for physiotherapy * Patients with cognitive capacity to understand Exclusion Criteria: * History of major psychiatric disorders, under psychiatric medication or optimal treatment for associated symptoms. * Long-term use of corticosteroid or nonsteroidal anti-inflammatory drugs up to one month before the study * Sedative medication during hospitalization. * Allergies or sensitivities to electrodes or the Nurosym device.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dementia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dementia Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Dementia Frailty syndrome

Contacts and locations

Locations

  • Balneal and Rehabilitation Sanatorium Techirghiol

    Techirghiol, Constanța County, 906100, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.